Oncternal Therapeutics Inc (NASDAQ:ONCT)

BATS BZX Real-Time Price
As of 2:29pm ET
 +0.0844 / +10.81%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Oncternal Therapeutics Inc have a median target of 9.50, with a high estimate of 15.00 and a low estimate of 3.50. The median estimate represents a +997.76% increase from the last price of 0.87.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Oncternal Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.90%
Growthannually -41.67%


Growthquarterly 60.10%
Growthannually -63.80%
Key to the earnings and sales forecast charts.